Rodman David Malcom

Rodman David Malcom is listed in filings as Chief Medical Officer at Mineralys Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 17, 2026, including sale activity. Recent filings connect the profile to Mineralys Therapeutics, Inc. (MLYS). The current snapshot covers public activity from Jan 6, 2026 to Jun 17, 2026. Reported amounts are shown as $114.6K to $235.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.